Hillary Lin, MD
About Hillary Lin, MD
Hillary Lin, MD, is an Internal Medicine Physician and the Founder of Livora Health, based in New York. With a background in oncology and extensive experience in healthcare startups, she has contributed to various advisory roles in the medical community.
Work at Livora Health
Hillary Lin, MD, is the Founder of Livora Health, a position she has held since 2024. The company is based in New York, New York, and focuses on longevity and transparency in healthcare. Livora Health aims to innovate in the healthcare sector by addressing critical issues related to patient care and health management.
Work at PlushCare
Since 2019, Hillary Lin has served as an Internal Medicine Physician at PlushCare. In this role, she provides comprehensive medical care to patients, utilizing her expertise in internal medicine to address a wide range of health concerns. Her tenure at PlushCare has contributed to the company's mission of delivering accessible healthcare services.
Previous Experience at Curio
Prior to her current roles, Hillary Lin co-founded Curio, where she served as CEO from 2020 to 2024. Under her leadership, Curio transitioned from a tech-enabled psychedelic-assisted therapy model to an AI-enabled patient navigation platform, reflecting her commitment to innovation in healthcare delivery.
Education and Expertise
Hillary Lin earned her Doctor of Medicine (MD) degree from Stanford University School of Medicine. She also holds a Bachelor of Science (BS) in Biology from Stanford University. Her educational background has equipped her with a strong foundation in medicine and research, which she has applied throughout her career.
Research and Advisory Roles
Hillary Lin has a significant background in research, having worked as a Cancer Researcher at Stanford University School of Medicine and as a Hepatology and Liver Cancer Researcher at Stanford Hepatology Clinic. In addition to her research, she actively contributes to the healthcare and startup community through advisory roles, including advising Cornell BioVenture eLab and the Melinda Gates-backed Headstream Accelerator.